The SIRPα-αCD123 antibodies presented here specifically bind to the AML cell line MOLM-13 in the presence of excess RBCs, in contrast to the high-affinity CD47-targeting antibody B6H12. The gene discussed is CD47; the disease is acute myeloid leukemia.